THERADAPTIVE Trademark

Trademark Overview


On Monday, December 7, 2020, a trademark application was filed for THERADAPTIVE with the United States Patent and Trademark Office. The USPTO has given the THERADAPTIVE trademark a serial number of 90364548. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, June 13, 2024. This trademark is owned by Theradaptive, Inc.. The THERADAPTIVE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

therapeutic proteins for medical use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, and chemotherapeutics; pharmaceutical and medicinal preparations and substances, namely, therapeutic proteins used for vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, and chemotherapeutics

research and development in connection with protein therapies for use in pharmaceutical products; medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, and protein therapeutics; development of therapeutics, namely, pharmaceutical and medical therapies for use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, and chemotherapeutics; scientific research and development
theradaptive

General Information


Serial Number90364548
Word MarkTHERADAPTIVE
Filing DateMonday, December 7, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, June 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements


Goods and Servicestherapeutic proteins for medical use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, and chemotherapeutics; pharmaceutical and medicinal preparations and substances, namely, therapeutic proteins used for vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, and chemotherapeutics
Goods and Servicesresearch and development in connection with protein therapies for use in pharmaceutical products; medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, and protein therapeutics; development of therapeutics, namely, pharmaceutical and medical therapies for use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, and chemotherapeutics; scientific research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTheradaptive, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrederick, MD 21703

Party NameTheradaptive, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFrederick, MD 21703

Trademark Events


Event DateEvent Description
Thursday, December 10, 2020NEW APPLICATION ENTERED
Friday, February 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 25, 2021ASSIGNED TO EXAMINER
Tuesday, May 25, 2021NON-FINAL ACTION WRITTEN
Tuesday, May 25, 2021NON-FINAL ACTION E-MAILED
Tuesday, May 25, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 15, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 15, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, September 15, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, September 15, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 9, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 9, 2022SOU EXTENSION 1 FILED
Thursday, June 9, 2022SOU EXTENSION 1 GRANTED
Saturday, June 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 12, 2022SOU TEAS EXTENSION RECEIVED
Monday, December 12, 2022SOU EXTENSION 2 FILED
Monday, December 12, 2022SOU EXTENSION 2 GRANTED
Wednesday, December 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 9, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 9, 2023SOU EXTENSION 3 FILED
Tuesday, May 9, 2023SOU EXTENSION 3 GRANTED
Thursday, May 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 11, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 11, 2023SOU EXTENSION 4 FILED
Monday, December 11, 2023SOU EXTENSION 4 GRANTED
Wednesday, December 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU EXTENSION 5 GRANTED
Thursday, June 13, 2024SOU EXTENSION 5 FILED